Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 57.0
(0.0%)
JPY 57.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 142.85 Million JPY | -58.6% |
| 2022 | 343.01 Million JPY | -34.39% |
| 2021 | 522.82 Million JPY | -4.17% |
| 2020 | 545.59 Million JPY | 20.95% |
| 2019 | 451.08 Million JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 248.85 Million JPY | 74.2% |
| 2024 Q2 | 130.34 Million JPY | -47.62% |
| 2023 FY | 142.85 Million JPY | -58.35% |
| 2023 Q2 | 302.97 Million JPY | -11.6% |
| 2023 Q1 | 342.7 Million JPY | -0.09% |
| 2023 Q3 | 255.1 Million JPY | -15.8% |
| 2023 Q4 | 142.85 Million JPY | -44.0% |
| 2022 Q3 | 161 Million JPY | 0.0% |
| 2022 Q4 | 343.01 Million JPY | 113.05% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 94.216% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 96.139% |
| Linical Co., Ltd. | 3 Billion JPY | 95.241% |
| Trans Genic Inc. | 2.25 Billion JPY | 93.671% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -6092.154% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 94.221% |
| AnGes, Inc. | 362.67 Million JPY | 60.611% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -33.696% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 99.807% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | 39.464% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 87.118% |
| Carna Biosciences, Inc. | 182.97 Million JPY | 21.926% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | 83.861% |
| RaQualia Pharma Inc. | 367.71 Million JPY | 61.151% |
| Chiome Bioscience Inc. | 291 Million JPY | 50.91% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 94.452% |
| PeptiDream Inc. | 22.79 Billion JPY | 99.373% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | 54.674% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | 78.518% |
| Healios K.K. | 4.53 Billion JPY | 96.848% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -26.98% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -46.453% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | 84.694% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | 85.242% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | 80.267% |
| StemCell Institute Inc. | 8.78 Million JPY | -1526.286% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | 5.552% |